Evidence map›Paper›PMID 25430780›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

The role of brain interleukin-1 in stress-enhanced fear learning.

Meghan E Jones, Christina L Lebonville, Daniel Barrus, Donald T Lysle

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Meghan E JonesBehavioral Neuroscience Program, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.
Christina L LebonvilleBehavioral Neuroscience Program, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.
Daniel BarrusBehavioral Neuroscience Program, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.
Donald T LysleBehavioral Neuroscience Program, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.
University of North Carolina at Chapel Hill · US

Funding

Training on Research in Drug AbuseT32DA007244 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Regina M Carelli · 1990 to 2026
$7.6M
Role of IL-1 in Heroin's Immune and Motivational EffectsR01DA034721 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FUCHS LOKENSGARD, RITA A, LYSLE, DONALD T · 2014 to 2018
$1.9M
NIDA NIH HHS R01 DA034721NIDA NIH HHS T32 DA007244
6 · The paper itself

Abstract

Posttraumatic stress disorder (PTSD) has been shown to be associated with pro-inflammatory markers, including elevated plasma levels of interleukin-1β (IL-1β). However, the precise role of neuroinflammation and central immune signaling on the development of this debilitating psychological disorder is not known. Here, we used stress-enhanced fear learning (SEFL), an animal model of the disorder, to examine the role of central IL-1β in PTSD. The results show that the severe stressor in SEFL induces a time-dependent increase in IL-1β immunoreactivity and mRNA expression within the dentate gyrus of the dorsal hippocampus (DH). There was no increase in IL-1β in the basolateral amygdala or the perirhinal cortex. Moreover, blocking the action of IL-1β following the severe stressor with IL-1 receptor antagonist (10 μg, intracerebroventricular (i.c.v.), 24 and 48 h after the stressor) prevented the development of SEFL. To provide further support for the role of IL-1β in the development of SEFL, we show that systemic morphine, a treatment which is known to reduce both PTSD and SEFL, also reduces IL-1β expression in the DH induced by the severe stressor. These studies provide the first evidence that IL-1 is involved SEFL and suggest that IL-1 signaling in the brain may have a critical role in the development of PTSD.

Indexed as

AnimalsBrainDisease Models, AnimalElectroshockFearImmunohistochemistryInterleukin-1betaLearningMaleMorphineNarcoticsRats, Sprague-DawleyRNA, MessengerStress Disorders, Post-TraumaticStress, PsychologicalTime FactorsIL1B protein, ratInterleukin-1betaMorphineNarcoticsRNA, Messenger

Identifiers

PMID25430780
PMCPMC4367475
OpenAlexW2057681905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.